PPIDT00299

Drug Information
NameTetanus immune globulin, human
SequenceEVQLVESGGGVVQPGRSLRLSCAASGFTFNNYAIHWVRQAPGKGLEWVAFISYDGSKNYYADSVKGRFTISRDNSKNTLFLQMNSLRPEDTAIYYCARVLFQQLVLYAPFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPQPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
DrugBank_IDDB11604
Typebiotech
IndicationFor use as prophylaxis against tetanus in patients who are injured and have incomplete of uncertain immunization status [FDA Label]. May also be used in the treatment of active tetanus.

Dosage Forms
Form Route Strength
Solution Intramuscular
250 IU
Liquid Intramuscular
0.165
Injection Intramuscular
250 [iU]/1mL
Solution Intramuscular
250 unit / mL
Solution Intramuscular
250 unit/1
Solution Intramuscular
250 [iU] /mL
Injection Intramuscular
250 units
Injection, solution Intramuscular; Parenteral
250 IU/1ML
Injection, solution Intramuscular; Parenteral
500 IU/2ML
Injection Intramuscular
250 iu/ml
Injection Intramuscular
500 iu/2ml
Injection, solution
Injection, solution Intramuscular
250 IU/mL
Injection Intramuscular
1500 IU/ML
Injection Intramuscular
5000 IU/ML
Injection, powder, for solution
250 UI/2ML
Injection, solution Intramuscular
Intramuscular
250 IU/2ml
Injection, solution Intramuscular; Parenteral
250 U.I./2ML
Injection, solution Intramuscular; Parenteral
500 U.I.
Solution Intramuscular
25000000 IU
Injection, solution Intramuscular
250 IU/2mL
Powder, for solution Intravenous
Intramuscular
Solution Intramuscular
250 iu/1ml
Solution Intramuscular
125 iu/1ml
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P04958 tetX Tetanus toxin Clostridium tetani (strain Massachusetts / E88) antibody Link